Anlon Healthcare Limited

Anlon Healthcare Limited is a Rajkot based chemical manufacturer that makes active pharmaceutical ingredients, pharmaceutical intermediates and nutraceutical compounds. Incorporated in 2013, it began commercial manufacturing in 2017 and supplies drug makers in India while also exporting to a number of overseas markets. Its output is made to the standards of the major pharmacopoeias, including the Indian, British, European, Japanese and United States compendia. The company runs a single manufacturing facility in Gujarat, certified to ISO 9001:2015 as well as GMP and WHO-GMP standards, with in house testing laboratories that handle quality control across the process. Its catalogue spans roughly 65 products already in commercial production, alongside a development pipeline of about 28 products at pilot scale and 49 at laboratory scale. It has filed 21 drug master files with regulators in various countries, and holds approvals from Brazil's ANVISA, China's NMPA and Japan's PMDA for its loxoprofen sodium dihydrate and loxoprofen acid ingredients. The promoters are Punitkumar R. Rasadia, Meet Atulkumar Vachhani and Mamata Punitkumar Rasadia. Revenue was about Rs 120 crore in FY2025, up from roughly Rs 67 crore in FY2024, while profit after tax roughly doubled to about Rs 21 crore. Growth rests on adding capacity at the existing plant and on converting the pilot and laboratory pipeline into commercial products, in a business where regulatory approvals and customer qualification cycles act as the main barriers to entry.